Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform
Marc Peeters,
Peter van Dam,
Marika Anna Rasschaert,
Christof Vulsteke,
Sven De Keersmaecker,
Lieselot Croes,
Ilse Van Brussel,
Jo Ravelingien,
Annelies Janssens,
Hans Prenen
Affiliations
Marc Peeters
Department of Medical Oncology, MOCA, University Hospital Antwerp (UZA), Antwerp, Belgium
Peter van Dam
Department of Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO), Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium
Marika Anna Rasschaert
Unit of Gynecologic Oncology, Department of Obstetrics & Gynecology, MOCA, University Hospital Antwerp (UZA), Antwerp, Belgium
Christof Vulsteke
Department of Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO), Center for Oncological Research (CORE), Antwerp University, Antwerp, Belgium
Sven De Keersmaecker
Unit of Gynecologic Oncology, Department of Obstetrics & Gynecology, MOCA, University Hospital Antwerp (UZA), Antwerp, Belgium
Lieselot Croes
Department of Medical Oncology, AZ Maria Middelares VZW, Gent, Belgium
Ilse Van Brussel
Remedus Bvba, Aartselaar, Belgium
Jo Ravelingien
Remedus Bvba, Aartselaar, Belgium
Annelies Janssens
Unit of Thoracic Oncology, MOCA, University Hospital Antwerp (UZA), Antwerp, Belgium
Hans Prenen
Department of Medical Oncology, MOCA, University Hospital Antwerp (UZA), Antwerp, Belgium
